Moreover, low levels of FOXO3 protein expression have been associated with poor prognosis in several types of tumors, including ovarian cancer, hepatocellular carcinoma, gastric cancer, and lung adenocarcinoma [[42], [43], [44], [45], [46], [47]]. This evidence concerns the gene FOXO3 and ovarian carcinoma.